First Manhattan
BIVV

First Manhattan’s Bioverativ Inc. Common Stock BIVV Stock Holding History

First Manhattan’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-564
Closed -$30K – 1521
2017
Q4 		$30K Sell
564
-119,696
-100% -$6.55M ﹤0.01% 1085
2017
Q3 		$6.86M Sell
120,260
-900
-0.7% -$52.7K 0.04% 218
2017
Q2 		$7.29M Hold
121,160
– – 0.04% 210
2017
Q1 		$6.6M Buy
+121,160
New +$5.97M 0.04% 218

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

First Manhattan's BIVV Position: Q1 2018 in Review

First Manhattan sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 564 shares — an estimated $30K sold.

First Manhattan first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.29M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • First Manhattan reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • First Manhattan sold 564 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $30K.
  • First Manhattan first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • First Manhattan's Bioverativ Inc. Common Stock position peaked at $7.29M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on First Manhattan's 13F filing for Q1 2018, filed 20 Apr 2018.